Log in to save to my catalogue

Risedronate prevents exercise-induced hypercalcemia but not nausea or vomit in humans: a double blin...

Risedronate prevents exercise-induced hypercalcemia but not nausea or vomit in humans: a double blin...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_461c8bcdbe5f4fc3aa0299584ec9514c

Risedronate prevents exercise-induced hypercalcemia but not nausea or vomit in humans: a double blind randomized controlled trial

About this item

Full title

Risedronate prevents exercise-induced hypercalcemia but not nausea or vomit in humans: a double blind randomized controlled trial

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2024-09, Vol.14 (1), p.22534-10, Article 22534

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Reportedly, nausea or vomiting after heavy exercise was associated with post-exercise increased blood calcium (Ca) levels, which was correlated with enhanced bone resorption. We conducted a randomized, double-blind, placebo-controlled trial, enrolling 104 healthy trained male members of the Japan Ground Self-Defense Forces. Risedronate (17.5 mg) or...

Alternative Titles

Full title

Risedronate prevents exercise-induced hypercalcemia but not nausea or vomit in humans: a double blind randomized controlled trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_461c8bcdbe5f4fc3aa0299584ec9514c

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_461c8bcdbe5f4fc3aa0299584ec9514c

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-024-73985-6

How to access this item